Cancer Treatment Centers of America - Chicago
Stem Cell Transplant and Cell Therapy Program
2520 Elisha Avenue
Zion, IL 60099
Direct phone: (888) 828-4888
Total transplants by cell source
- Marrow: 0
- PBSC: 24
- Cord Blood: 0
- Autologous (PBSC or Marrow): 30
About the center
Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center is FACT (Foundation for the Accreditation of Cellular Therapy) accredited. The Stem Cell Transplant and Cell Therapy Program at Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center (Midwestern) provides state-of-the-art stem cell transplantation therapies for hematologic malignancies such as acute and chronic leukemias, myelodysplastic syndromes (MDS), lymphomas, and multiple myeloma. The program offers a complete and comprehensive array of transplant services, including autologous, allogeneic, haplo-identical, cord blood transplantation and adoptive immunotherapies. These treatments are combined with integrative therapies and patients are cared for by one Hematologic Patient Empowered Care (PEC) team from evaluation through the stem cell transplant process and beyond to ensure continuity of care.
This center has been performing allogeneic transplants since 1998 and has been an NMDP/Be The Match transplant center since September 2011.
Adult - Syed Abutalib, Syed Norman Haider, Istvan Redei
Marrow/PBSC, single cord, and double cord
Cord blood transplants performed on
Other programs and services
Information on this topic was not provided.
Overall center survival
Patient survival information for this center
This center's actual 1-year survival results are similar to the expected rate for this center.
The survival information we have for this center includes ONLY:
- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2015, 2016, 2017, and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 30 patients.
The actual 1-year survival of these patients is 66.5%.
Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 54.5% and 85.8%.
For help with understanding these statistics, please see Understanding Transplant Outcomes.
For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report at bloodcell.transplant.hrsa.gov.
Transplants reported (From January 1, 2017 to December 31st, 2018 as reported by the centers)
|Both marrow & PBSC
Transplants by disease
Number of transplants by age reported from January 1, 2017 to December 31st, 2018 (includes marrow, PBSC and cord blood)
Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.
Centers are not required to report autologous transplants so the numbers might be incomplete.
More information about transplants for this disease can be found:
Transplant center resources
If you have transplant-related questions, please call the transplant center's direct phone number.
If you have questions about costs and financial services at this center, please call the transplant center's direct phone number.
Be The Match patient navigators
Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.
Inside the United States: 1 (888) 999-6743
Outside the United States: 1 (763) 406-3410.
(Long distance or international charges may apply.)
No survivorship program information is available. Contact the center for information about post-transplant care.